Hyperkalemia Recruiting Phase 3 Trials for Sodium zirconium cyclosilicate (DB14048)

Also known as: Hyperkalemia (HK) / Hyperkalaemia / Hyperpotassaemia / Hyperpotassemia / Potassium overload / Potassium [K] excess

IndicationStatusPhase
DBCOND0003949 (Hyperkalemia)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03813407An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaTreatment
NCT04727528Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney DiseaseTreatment
NCT05056727A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of HyperkalaemiaTreatment
NCT04847232Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)Treatment
NCT05004363Lokelma for RAAS Maximisation in CKD & Heart Failure.Treatment